{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T16:44:11Z","timestamp":1775925851470,"version":"3.50.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U54HD090255"],"award-info":[{"award-number":["1U54HD090255"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR064300"],"award-info":[{"award-number":["R01AR064300"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ymthe.2020.11.021","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T09:50:37Z","timestamp":1605865837000},"page":"1086-1101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8300-3124","authenticated-orcid":false,"given":"Matthias R.","family":"Lambert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janelle M.","family":"Spinazzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey J.","family":"Widrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pakula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Conner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice E.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane M.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6126-0242","authenticated-orcid":false,"given":"Louis M.","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.11.021_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.11.021_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD global database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2020.11.021_bib3","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.11.021_bib4","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1083\/jcb.119.5.1183","article-title":"Direct visualization of the dystrophin network on skeletal muscle fiber membrane","volume":"119","author":"Straub","year":"1992","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib5","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","article-title":"Membrane organization of the dystrophin-glycoprotein complex","volume":"66","author":"Ervasti","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.11.021_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-genom-090314-025003","article-title":"The pathogenesis and therapy of muscular dystrophies","volume":"16","author":"Guiraud","year":"2015","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ymthe.2020.11.021_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00007.2015","article-title":"Absence of dystrophin disrupts skeletal muscle signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy","volume":"96","author":"Allen","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymthe.2020.11.021_bib8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/japplphysiol.00587.2003","article-title":"Susceptibility to sarcomere injury induced by single stretches of maximally activated muscles of mdx mice","volume":"96","author":"Consolino","year":"2004","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.ymthe.2020.11.021_bib9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2020.11.021_bib11","series-title":"Duchenne Muscular Dystrophy","author":"Emery","year":"2015"},{"key":"10.1016\/j.ymthe.2020.11.021_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13023-017-0631-3","article-title":"The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review","volume":"12","author":"Ryder","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2020.11.021_bib13","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-deficient cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mus.25953","article-title":"Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies","volume":"57","author":"Hightower","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2020.11.021_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/WNL.0b013e318207afeb","article-title":"SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy","volume":"76","author":"Pegoraro","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2020.11.021_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.23819","article-title":"LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy","volume":"73","author":"Flanigan","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ana.24370","article-title":"Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study","volume":"77","author":"Bello","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib18","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ajhg.2016.08.023","article-title":"Association study of exon variants in the NF-\u03baB and TGF\u03b2 pathways identifies CD40 as a modifier of Duchenne muscular dystrophy","volume":"99","author":"Bello","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2020.11.021_bib19","doi-asserted-by":"crossref","first-page":"14143","DOI":"10.1038\/ncomms14143","article-title":"Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy","volume":"8","author":"Hogarth","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2020.11.021_bib20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41431-019-0563-6","article-title":"TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy","volume":"28","author":"Spitali","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2020.11.021_bib21","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/4033","article-title":"Expression of full-length utrophin prevents muscular dystrophy in mdx mice","volume":"4","author":"Tinsley","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.11.021_bib22","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1073\/pnas.1013067108","article-title":"Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice","volume":"108","author":"Amenta","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.021_bib23","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/hmg\/ddt514","article-title":"Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-\u03b2 signalling","volume":"23","author":"Acu\u00f1a","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.11.021_bib24","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1073\/pnas.1324242111","article-title":"Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair","volume":"111","author":"Swaggart","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.021_bib25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/mt.2015.105","article-title":"Galectin-1 protein therapy prevents pathology and improves muscle function in the mdx mouse model of Duchenne muscular dystrophy","volume":"23","author":"Van Ry","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.11.021_bib26","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/hmg\/ddu615","article-title":"Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and \u03b17 integrin","volume":"24","author":"Marshall","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.11.021_bib27","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1172\/JCI37662","article-title":"Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-\u03b2","volume":"119","author":"Vetrone","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.11.021_bib28","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2015.10.049","article-title":"Jagged 1 rescues the Duchenne muscular dystrophy phenotype","volume":"163","author":"Vieira","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.11.021_bib29","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1073\/pnas.1703556114","article-title":"Repression of phosphatidylinositol transfer protein \u03b1 ameliorates the pathology of Duchenne muscular dystrophy","volume":"114","author":"Vieira","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.021_bib30","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.nmd.2008.06.385","article-title":"Ringo, a golden retriever muscular dystrophy (GRMD) dog with absent dystrophin but normal strength","volume":"18","author":"Ambr\u00f3sio","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2020.11.021_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.nmd.2009.10.011","article-title":"Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog","volume":"20","author":"Zucconi","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2020.11.021_bib32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.nmd.2015.02.007","article-title":"A normal life without muscle dystrophin","volume":"25","author":"Zatz","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2020.11.021_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/bs.mcb.2016.11.004","article-title":"Muscular dystrophy modeling in zebrafish","volume":"138","author":"Li","year":"2017","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JND-190389","article-title":"Discovery of novel therapeutics for muscular dystrophies using zebrafish phenotypic screens","volume":"6","author":"Widrick","year":"2019","journal-title":"J.\u00a0Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2020.11.021_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1242\/dev.123.1.399","article-title":"Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva","volume":"123","author":"Granato","year":"1996","journal-title":"Development"},{"key":"10.1016\/j.ymthe.2020.11.021_bib36","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1242\/dev.00799","article-title":"Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo","volume":"130","author":"Bassett","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.ymthe.2020.11.021_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1440-1681.2004.04030.x","article-title":"Identification of a zebrafish model of muscular dystrophy","volume":"31","author":"Bassett","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddn337","article-title":"Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin","volume":"18","author":"Guyon","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.11.021_bib39","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1073\/pnas.1102116108","article-title":"Drug screening in a zebrafish model of Duchenne muscular dystrophy","volume":"108","author":"Kawahara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.021_bib40","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.ddtec.2012.03.001","article-title":"Zebrafish based small molecule screens for novel DMD drugs","volume":"10","author":"Kawahara","year":"2013","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib41","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/hmg\/ddt579","article-title":"Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling","volume":"23","author":"Kawahara","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.11.021_bib42","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1093\/hmg\/ddu185","article-title":"Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy","volume":"23","author":"Waugh","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.11.021_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymthe.2019.08.016","article-title":"The SINE compound KPT-350 blocks dystrophic pathologies in DMD zebrafish and mice","volume":"28","author":"Hightower","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.11.021_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13395-020-00251-4","article-title":"A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy","volume":"10","author":"Farr","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2020.11.021_bib45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/path.4054","article-title":"Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy","volume":"228","author":"Percival","year":"2012","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib46","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ana.24214","article-title":"Sildenafil does not improve cardiomyopathy in Duchenne\/Becker muscular dystrophy","volume":"76","author":"Leung","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib47","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1212\/WNL.0000000000000498","article-title":"PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy","volume":"82","author":"Nelson","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2020.11.021_bib48","doi-asserted-by":"crossref","first-page":"bio053363","DOI":"10.1242\/bio.053363","article-title":"Effect of serotonin modulation on dystrophin-deficient zebrafish","volume":"9","author":"Spinazzola","year":"2020","journal-title":"Biol. Open"},{"key":"10.1016\/j.ymthe.2020.11.021_bib49","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bbrc.2012.06.040","article-title":"Quantification of birefringence readily measures the level of muscle damage in zebrafish","volume":"423","author":"Berger","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2020.11.021_bib50","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1242\/jeb.003939","article-title":"Modulation of locomotor activity in larval zebrafish during light adaptation","volume":"210","author":"Burgess","year":"2007","journal-title":"J.\u00a0Exp. Biol."},{"issue":"20","key":"10.1016\/j.ymthe.2020.11.021_bib51","first-page":"923","article-title":"A behavioral assay to measure responsiveness of zebrafish to changes in light intensities","author":"Emran","year":"2008","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2020.11.021_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/biomedicines7010023","article-title":"Zebrafish larvae as a behavioral model in neuropharmacology","volume":"7","author":"Basnet","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymthe.2020.11.021_bib53","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1152\/physiolgenomics.00088.2016","article-title":"Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy","volume":"48","author":"Widrick","year":"2016","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.ymthe.2020.11.021_bib54","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/zeb.2013.0875","article-title":"Impaired cardiovascular function caused by different stressors elicits a common pathological and transcriptional response in zebrafish embryos","volume":"10","author":"Chen","year":"2013","journal-title":"Zebrafish"},{"key":"10.1016\/j.ymthe.2020.11.021_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/er.2013-1053","article-title":"Clinical and molecular genetics of the phosphodiesterases (PDEs)","volume":"35","author":"Azevedo","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ymthe.2020.11.021_bib56","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41573-019-0033-4","article-title":"Therapeutic targeting of 3\u2032,5\u2032-cyclic nucleotide phosphodiesterases: inhibition and beyond","volume":"18","author":"Baillie","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2020.11.021_bib57","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1139\/y02-149","article-title":"Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle","volume":"80","author":"Bloom","year":"2002","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib58","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1139\/y05-085","article-title":"Age-related alterations in cyclic nucleotide phosphodiesterase activity in dystrophic mouse leg muscle","volume":"83","author":"Bloom","year":"2005","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib59","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-510X(92)90171-G","article-title":"Calcium, calmodulin and 3\u2032,5\u2032-cyclic nucleotide phosphodiesterase activity in human muscular disorders","volume":"109","author":"Mishra","year":"1992","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ymthe.2020.11.021_bib60","doi-asserted-by":"crossref","first-page":"e91514","DOI":"10.1371\/journal.pone.0091514","article-title":"Dysfunctional muscle and liver glycogen metabolism in mdx dystrophic mice","volume":"9","author":"Stapleton","year":"2014","journal-title":"PLoS One"},{"issue":"204","key":"10.1016\/j.ymthe.2020.11.021_bib61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-642-17969-3_14","article-title":"Evaluation of the therapeutic utility of phosphodiesterase 5A inhibition in the mdx mouse model of Duchenne muscular dystrophy","author":"Percival","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib62","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1096\/fj.201700249R","article-title":"Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy","volume":"31","author":"Nio","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2020.11.021_bib63","doi-asserted-by":"crossref","first-page":"796","DOI":"10.15252\/emmm.201506085","article-title":"A novel thermoregulatory role for PDE10A in mouse and human adipocytes","volume":"8","author":"Hankir","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2020.11.021_bib64","doi-asserted-by":"crossref","first-page":"E342","DOI":"10.1152\/ajpendo.00691.2010","article-title":"cGMP phosphodiesterase inhibition improves the vascular and metabolic actions of insulin in skeletal muscle","volume":"301","author":"Genders","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2020.11.021_bib65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.119.042178","article-title":"A novel role of cyclic nucleotide phosphodiesterase 10A in pathological cardiac remodeling and dysfunction","volume":"141","author":"Chen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2020.11.021_bib66","doi-asserted-by":"crossref","first-page":"19079","DOI":"10.1073\/pnas.1013077107","article-title":"Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy","volume":"107","author":"Adamo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.11.021_bib67","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jcp.25075","article-title":"Pathways implicated in tadalafil amelioration of duchenne muscular dystrophy","volume":"231","author":"De Arcangelis","year":"2016","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib68","doi-asserted-by":"crossref","first-page":"e003911","DOI":"10.1161\/JAHA.116.003911","article-title":"Tadalafil treatment delays the onset of cardiomyopathy in dystrophin-deficient hearts","volume":"5","author":"Hammers","year":"2016","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.ymthe.2020.11.021_bib69","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1152\/japplphysiol.00664.2018","article-title":"Effects of PDE5 inhibition on dystrophic muscle following an acute bout of downhill running and endurance training","volume":"126","author":"Batra","year":"2019","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.ymthe.2020.11.021_bib70","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1212\/WNL.0000000000004570","article-title":"A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy","volume":"89","author":"Victor","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2020.11.021_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinph.2019.09.023","article-title":"Intramuscular blood flow in Duchenne and Becker muscular dystrophy: quantitative power Doppler sonography relates to disease severity","volume":"131","author":"Dietz","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib72","doi-asserted-by":"crossref","first-page":"e120493","DOI":"10.1172\/jci.insight.120493","article-title":"A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies","volume":"3","author":"Serafini","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2020.11.021_bib73","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1242\/dev.001115","article-title":"Controlling morpholino experiments: don\u2019t stop making antisense","volume":"135","author":"Eisen","year":"2008","journal-title":"Development"},{"key":"10.1016\/j.ymthe.2020.11.021_bib74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/BSS2007c21","article-title":"Trafficking of phosphatidylinositol by phosphatidylinositol transfer proteins","volume":"74","author":"Cockcroft","year":"2007","journal-title":"Biochem. Soc. Symp."},{"key":"10.1016\/j.ymthe.2020.11.021_bib75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10409230500519573","article-title":"The diverse biological functions of phosphatidylinositol transfer proteins in eukaryotes","volume":"41","author":"Phillips","year":"2006","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib76","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1139\/bcb-2015-0152","article-title":"Ligand and membrane-binding behavior of the phosphatidylinositol transfer proteins PITP\u03b1 and PITP\u03b2","volume":"94","author":"Baptist","year":"2016","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib77","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/hmg\/ddr015","article-title":"Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice","volume":"20","author":"Kim","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.11.021_bib78","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/hmg\/ddn358","article-title":"Myogenic Akt signaling upregulates the utrophin-glycoprotein complex and promotes sarcolemma stability in muscular dystrophy","volume":"18","author":"Peter","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.11.021_bib79","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1083\/jcb.201110032","article-title":"Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration","volume":"197","author":"Marshall","year":"2012","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib80","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1172\/JCI73579","article-title":"MicroRNA-486-dependent modulation of DOCK3\/PTEN\/AKT signaling pathways improves muscular dystrophy-associated symptoms","volume":"124","author":"Alexander","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.11.021_bib81","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.yexcr.2006.04.024","article-title":"Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway","volume":"312","author":"Peter","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ymthe.2020.11.021_bib82","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1093\/hmg\/ddn264","article-title":"Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle","volume":"17","author":"Blaauw","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2020.11.021_bib83","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1128\/MCB.22.13.4803-4814.2002","article-title":"Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth","volume":"22","author":"Takahashi","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib84","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/onc.2014.94","article-title":"Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and \u03b2-catenin-dependent TCF transcriptional activity","volume":"34","author":"Li","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2020.11.021_bib85","doi-asserted-by":"crossref","first-page":"33501","DOI":"10.1074\/jbc.M303591200","article-title":"Mice lacking phosphatidylinositol transfer protein-\u03b1 exhibit spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia","volume":"278","author":"Alb","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2020.11.021_bib86","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/21678707.2016.1240613","article-title":"Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophy","volume":"4","author":"Spinazzola","year":"2016","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ymthe.2020.11.021_bib87","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1021\/jm2009138","article-title":"Highly potent, selective, and orally active phosphodiesterase 10A inhibitors","volume":"54","author":"Malamas","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ymthe.2020.11.021_bib88","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1021\/jm900521k","article-title":"Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophrenia","volume":"52","author":"Verhoest","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"issue":"82","key":"10.1016\/j.ymthe.2020.11.021_bib89","first-page":"e50925","article-title":"Analysis of skeletal muscle defects in larval zebrafish by birefringence and touch-evoke escape response assays","author":"Smith","year":"2013","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2020.11.021_bib90","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6750-8-21","article-title":"Systolic and diastolic ventricular function in zebrafish embryos: influence of norepenephrine, MS-222 and temperature","volume":"8","author":"Denvir","year":"2008","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.ymthe.2020.11.021_bib91","first-page":"e2591","article-title":"Isolation of primary human skeletal muscle cells","volume":"7","author":"Spinazzola","year":"2017","journal-title":"Bio Protoc."},{"key":"10.1016\/j.ymthe.2020.11.021_bib92","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.18632\/oncotarget.6705","article-title":"\u03b2-Catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620306195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620306195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:59:50Z","timestamp":1761501590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620306195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1525001620306195"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.11.021","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}